+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Takeda Pharmaceutical Company Limited - logo

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

Chronic Obstructive Pulmonary Disease: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease: Global Drug Forecast and Market Analysis to 2028

  • Report
  • March 2020
  • 154 Pages
  • Global
From
Traumatic Brain Injury - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Traumatic Brain Injury - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 395 Pages
  • Global
From
Neuromyelitis Optica (Devic's Syndrome) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Neuromyelitis Optica (Devic's Syndrome) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 103 Pages
  • Global
From
Skeletal Dysplasia - Global Strategic Business Report - Product Thumbnail Image

Skeletal Dysplasia - Global Strategic Business Report

  • Report
  • July 2025
  • 378 Pages
  • Global
From
Fibrin Sealants - Global Strategic Business Report - Product Thumbnail Image

Fibrin Sealants - Global Strategic Business Report

  • Report
  • July 2025
  • 92 Pages
  • Global
From
Idiopathic Thrombocytopenic Purpura Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 277 Pages
  • Global
From
Acquired Orphan Blood Diseases Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Acquired Orphan Blood Diseases Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 250 Pages
  • Global
From
Rare Hemophilia Factors - Global Strategic Business Report - Product Thumbnail Image

Rare Hemophilia Factors - Global Strategic Business Report

  • Report
  • July 2025
  • 132 Pages
  • Global
From
Bleeding Disorder Drugs - Global Strategic Business Report - Product Thumbnail Image

Bleeding Disorder Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 488 Pages
  • Global
From
Hemophilia Treatment - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 476 Pages
  • Global
From
Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 269 Pages
  • Global
From
Duodenal Ulcer Treatment - Global Strategic Business Report - Product Thumbnail Image

Duodenal Ulcer Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 380 Pages
  • Global
From
Gastric Motility Disorder Drugs - Global Strategic Business Report - Product Thumbnail Image

Gastric Motility Disorder Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 371 Pages
  • Global
From
Gastroparesis Treatment - Global Strategic Business Report - Product Thumbnail Image

Gastroparesis Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 463 Pages
  • Global
From
Industry Snapshots: Japan Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: Japan Pharmaceuticals

  • Newsletter
  • July 2025
  • 75 Pages
  • Japan
From
Company Snapshots: Japan Pharmaceutical - Product Thumbnail Image

Company Snapshots: Japan Pharmaceutical

  • Newsletter
  • July 2025
  • 35 Pages
  • Japan
From
Ophthalmic Drugs Market by Product Type, Drug Class, Dosage Form, Route of Administration, Therapeutic Area, Patient Demographics, End User - Global Forecast to 2030 - Product Thumbnail Image

Ophthalmic Drugs Market by Product Type, Drug Class, Dosage Form, Route of Administration, Therapeutic Area, Patient Demographics, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 184 Pages
  • Global
From
Novel T-Cell Immunotherapies Market: Focus on T-Cells, Tregs, Activated T-Cells, Virus-driven T-Cells & T-Cell Vaccines - Distribution by Type of T-Cell Therapy, Target Indications , Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Novel T-Cell Immunotherapies Market: Focus on T-Cells, Tregs, Activated T-Cells, Virus-driven T-Cells & T-Cell Vaccines - Distribution by Type of T-Cell Therapy, Target Indications , Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • June 2021
  • 193 Pages
  • Global
From
Celiac Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Celiac Disease Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 371 Pages
  • Global
From
Dyspepsia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dyspepsia Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 566 Pages
  • Global
From
Loading Indicator